Most Recent
BHP Group Ltd has appealed a ruling allowing foreign group members to be part of a shareholder class action against the mining giant over the Fundao dam failure in Brazil five years ago.
The High Court will not hear cleaning services giant Spotless Group's challenge to a ruling that found it must pay redundancy entitlements to a group of workers it sacked.
Women's fashion designer Pinnacle Runway has cut its losses and dropped its challenge to a ruling that found a rival's use of the name 'Delphine' to describe a bikini style did not constitute trade mark infringement, after a judge hit the company with indemnity costs for pursuing the 'ill-advised' lawsuit.
The prefab concrete specialist behind Sydney's Opal Tower has appealed a ruling letting its insurers off the hook to pay costs in advance incurred in defending cross-claims in two lawsuits over the ill-fated tower.
Three media companies have been granted special leave by the High Court to challenge a finding that they could be held liable for allegedly defamatory remarks left under news articles they posted on Facebook.
A sacked Norton Rose Fulbright partner is challenging a $160,000 award handed down by a judge who found the law firm intentionally deceived him in litigation over his dismissal, arguing the sum is "manifestly inadequate".
The ACCC has reached the end of the line in its challenge to Pacific National's $205 million acquisition of Aurizon's Acacia Ridge Terminal in Queensland, with the High Court dismissing the competition regulator's application to take up the appeal.
Convenience store chain 7-Eleven has asked the High Court to find courts do not have the power to make common fund orders at settlement or judgment in a class action, one year after the High Court ruled common fund orders could not be made in the early part of a representative proceeding.
The Sydney Opera House is challenging a ruling that denied its opposition to a trade mark application filed by a China-Australia trade association that featured an image of the opera house sails together with the Great Wall of China.
A judge hearing Pfizer's application for preliminary discovery against Sandoz over its possible launch of an Enbrel biosimilar has found that such an application must be based on a current belief that the applicant could be entitled to relief.